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1. Introduction 
Adenosine 3’,5’-monophosphate (cyclic AMP) 
when added to or generated in several neural systems 
modifies their cell-firing and consequent activity [ 121, 
and is pictured to do so by activating protein kinases 
which control ion movements [3,4] so altering cell- 
polarization and discharge. only small quantities of 
cyclic AMP are needed for this, such as can be 
calculated to be formed by a single stimulating pulse 
or in a few msec. [5] . Cell-firing in the brain is 
frequently continuous or repetitive, and under such 
circumstances cyclic AMP accumulates; stimulation 
in vitro raises its concentration from 1 to 30 or 
40 nmol/g [6]. Studies with labelled precursors give 
evidence for locally increased concentrations 20 times 
these values [5,7,8] . After such increase, cyclic AMP 
can be visualized in nerve-cell bodies by immuno- 
fluorescence techniques [9] and remains above its 
original level for at least 10 to 30 min [7,10] . 
2. Hypothesis 
It is now postulated that cyclic AMP travels along 
nerve cell axons and dendrites during this 10 min or 
more, reaching further sites where, again, it conditions 
cell-discharge and consequent phenomena. 
The following points indicate the feasibility of this 
proposal. It is inherent in the action of cyclic AMP as 
an intracellular messenger that it migrate across normal 
cellular distances in reaching, e.g., ribosomes, the 
nucleus or other organelles [ 1 l] . The suggestion 
[3,4] that in conditioning cell-firing cyclic AMP acts 
at membrane proteins which are immediately adjacent 
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or contiguous to its site of generation, is not a general 
feature in its action, though it is relevant if very 
prompt neural action is the main characteristic to be 
explained. The phosphodiesterases which normally 
limit the action of cyclic AMP by hydrolysing it are 
subject to complex activation and control in neural 
systems [ 111. A soluble, cytoplasmic, enzyme has 
relatively low affinity for cyclic AMP: apparent K,, 
approx. 1 mM [ 121, which is consistent with the 
persistence of moderate concentrations of the 
nucleotide. A subsynaptic, membrane-bound enzyme 
is of high affinity: apparent KM for cyclic AMP, about 
1 I.~M [ 131; movement of cyclic AMP away from its 
membrane-site of generation thus removes it from a 
major site where loss may occur. 
Intracellular movements of adenine nucleotides 
were postulated on finding that nerve terminal prepara- 
tions from the neocortex released adenine derivatives, 
including cyclic AMP, in quantities up to 1.5% of 
their content/min [ 14-161 whereas generation of 
cyclic AMP was most readily seen at nerve cell bodies 
[9]. Axonal and dendritic flow of adenine nucleotides 
has indeed been observed by autoradiographic methods 
[ 17,181 occurring at rates of some 15-60 pm/min in 
cerebral or spinal neurons of cats and rabbits. Many 
functions are performed by such cytoplasmic flow in 
neural systems (table l), including some concerning 
neurotransmitters, but the movement of cyclic AMP 
is distinct from these in bringing the already active 
second messenger to its site of action without the need 
for release by further stimulation. Cytoplasmic flow of 
cyclic AMP thus constitutes a slowly-moving nerve- 
signal, travelling at 0.25 to 1 pm/set in contrast to 
the l-l 00 m/set of the orthodox nerve impulse. 
‘Readout’ of the signal is pictured to occur at the 
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Table 1 
Cytoplasmic movement of a second messenger 
Recognized roles for cytoplasmic flow [ 16- 1 Y ] 
1. Supply from the cell body of metabolites, enzymes, 
ribonucleic acid, organelles. 
2. 
3. 
Transport to the cell body of materials for re-use; 
retrograde movement of substances participating in 
control of protein and ribonucleic acid synthesis. 
Movement of neurotransmitters including acetylcho- 
line and catecholamines, free or vesiculated. To act, 
these require (i) release by nerve impulse; (ii) travel to 
extracellular sites. 
Now proposed 
Cyclic AMP which is formed intracellularly near its primary 
site of action, may act: (i) locally; and (ii) at other sites after 
translocation by axonal or dendritic flow: so constituting, 
without further mechanism for release or activation, a nerve- 
signal travelling at 15-60 nm/min. 
many sites at which cyclic AMP (locally generated) is 
already considered [3,4] to activate protein kinases 
controlling membrane permeability: this simplification 
is specific to ‘second messengers’ akin to cyclic AMP. 
Mobile protein kinase complexes have been suggested 
as mediating some intracellular actions of cyclic AMP 
[20] and the proposals of Table 1 may be extended in 
an analogous way. 
Comment 
Recognition of a slowly-moving neural signal can 
assist interpretation of cell-firing patterns in the brain. 
Thus mammalian cerebellar Purkinje cells [21,22] 
receive among their inputs noradrenergic innervation, 
stimulation of which augments their cyclic AMP [9] 
in association with concomitant changes in firing rates. 
Fluctuations in their firing rates occur also over periods 
lasting from a few seconds to several minutes and are 
not readily interpreted [22] ; they however vary with 
cell activation which has occurred earlier. The cells 
carry dendritic trees extending up to 100 pm from the 
cell body [23] ; cyclic AMP proceeding as in table 1 
would traverse this distance in 1.6 to 6 min and during 
this time, by present proposals, could modify cell 
firing. The channel-capacity of nerve axons for 
transmission by electrical impulses is large but limited 
[24] and the complementary mode of transmission 
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proposed in table 1 merits exploration in other cerebral 
processes which occupy some minutes or more, as 
shortterm memory [25] and aspects of problem-solving 
WI. 
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